Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients
Open Access
- 10 June 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (12), 2571
- https://doi.org/10.3390/jcm10122571
Abstract
Patients in end-stage heart failure can experiment cardiogenic shock and may not be weanable from dobutamine. The fate of these patients is a challenge for doctors, patients, family, and the institution. Dobutamine use at home can be a solution. The aim of the present study was to assess the outcome, biological predictors, and safety of dobutamine use at home in dobutamine-dependent patients. All consecutive dobutamine-dependent patients discharged with continuous home intravenous dobutamine, from a single tertiary center between February 2014 and November 2019, were retrospectively analyzed. A total of 19 patients (age 65 ± 10 years) were followed for one year. At one-year, the survival rate was 32%, (6/19). Five (26%) patients had an adverse event related to the intravenous catheter. In a multivariate logistic regression analysis, the combination of a glomerular filtration rate >60 mL/min and a brain natriuretic peptide level p < 0.001). Management of dobutamine-unweanable patients after cardiogenic shock may involve dobutamine at home to permit a home return. This strategy allows a significant survival and few readmissions, and, if eligible, access to surgical strategies, such as heart transplantation. Simple biological markers at discharge can identify severe patients to refer to palliative care and good responders.Keywords
This publication has 20 references indexed in Scilit:
- Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart FailureCirculation: Heart Failure, 2015
- The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and managementExpert Review of Cardiovascular Therapy, 2015
- Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines CommitteeJournal of Cardiac Failure, 2015
- Dobutamine Induced Eosinophilic Myocarditis and Right Heart Failure Requiring Emergent Biventricular Assist Device ImplantationAsaio Journal, 2015
- Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trialEuropean Journal of Heart Failure, 2014
- B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection FractionJournal of the American College of Cardiology, 2013
- Prognosis on Chronic Dobutamine or Milrinone Infusions for Stage D Heart FailureCirculation: Heart Failure, 2009
- The Use of Continuous Milrinone Therapy as Bridge to Transplant Is Safe in Patients With Short Waiting TimesJournal of Cardiac Failure, 2008
- Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failureJournal of Cardiac Failure, 2003
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001